These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4028922)

  • 1. Should visual field examination be a routine part of ophthalmic practice?
    Gutteridge IF
    Doc Ophthalmol; 1985 Jun; 59(4):323-39. PubMed ID: 4028922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Friedmann Visual Field Analyser Mark II. Part 2. Results from a population with induced visual field defects.
    Henson DB; Dix SM
    Br J Ophthalmol; 1984 Jul; 68(7):463-7. PubMed ID: 6733070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Friedmann Visual Field Analyser Mark II--technical evaluation and clinical results.
    de Boer RW; van den Berg TJ; Beintema MR; Greve EL; Höppener J; Verduin WM
    Doc Ophthalmol; 1982 Dec; 53(4):331-42. PubMed ID: 7166100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of glaucomatous visual field defects with the Mark II Friedmann analyzer.
    Hicks BC; Anderson DR
    Am J Ophthalmol; 1983 May; 95(5):692-700. PubMed ID: 6846460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual field screening with a laptop computer system.
    Bruun-Jensen J
    Optometry; 2011 Sep; 82(9):519-27. PubMed ID: 21871394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blue versus white stimuli in ocular hypertension with the Friedmann Mark 1 Visual Field Analyser.
    Hugkulstone CE; Vernon SA
    Eye (Lond); 1992; 6 ( Pt 4)():356-60. PubMed ID: 1478305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of frequency doubling perimetry in detecting neuro-ophthalmic visual field defects.
    Thomas D; Thomas R; Muliyil JP; George R
    Am J Ophthalmol; 2001 Jun; 131(6):734-41. PubMed ID: 11384569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glaucoma diagnostics.
    Geimer SA
    Acta Ophthalmol; 2013 Feb; 91 Thesis 1():1-32. PubMed ID: 23384049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The working threshold approach to Friedmann visual field analyser screening.
    Gutteridge IF
    Ophthalmic Physiol Opt; 1983; 3(1):41-6. PubMed ID: 6866521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the Friedmann visual field analyser in detecting glaucoma damage].
    Xu LA
    Zhonghua Yan Ke Za Zhi; 1989 Mar; 25(2):80-3. PubMed ID: 2507257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Friedmann Visual Field Analyser Mark II. Part 1. Results from a normal population.
    Henson DB; Dix SM; Oborne AC
    Br J Ophthalmol; 1984 Jul; 68(7):458-62. PubMed ID: 6733069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How effective is perimetry in current practice?
    Trobe JD
    Ophthalmology; 1983 Nov; 90(11):1380-3. PubMed ID: 6664679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A visual field screening protocol for glaucoma.
    Rabin S; Kolesar P; Podos SM; Wilensky JT
    Am J Ophthalmol; 1981 Oct; 92(4):630-5. PubMed ID: 7027800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudopapilloedema with and without verified optic disc drusen. A clinical analysis II: visual fields.
    Mustonen E
    Acta Ophthalmol (Copenh); 1983 Dec; 61(6):1057-66. PubMed ID: 6659908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dethecting glaucomatous damage with the Friedmann analyzer compared with te Goldmann perimeter and evaluation of stereoscopic photographs of the optic disk.
    Batko KA; Anctil JL; Anderson DR
    Am J Ophthalmol; 1983 Apr; 95(4):435-47. PubMed ID: 6837687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the oculokinetic perimetry glaucoma screener with two types of visual field analyser.
    Greve M; Chisholm IA
    Can J Ophthalmol; 1993 Aug; 28(5):201-6. PubMed ID: 8221366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Peritest automatic perimeter in screening for glaucomatous visual field defects.
    Douglas GR
    Can J Ophthalmol; 1983 Dec; 18(7):318-20. PubMed ID: 6671150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual loss in pseudotumor cerebri. Incidence and defects related to visual field strategy.
    Wall M; George D
    Arch Neurol; 1987 Feb; 44(2):170-5. PubMed ID: 3813933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated automatic visual field screening in a cohort study.
    Bengtsson B
    Acta Ophthalmol (Copenh); 1985 Apr; 63(2):242-4. PubMed ID: 4003054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Swedish interactive thresholding algorithm fast perimetry be used as an alternative to goldmann perimetry in neuro-ophthalmic practice?
    Szatmáry G; Biousse V; Newman NJ
    Arch Ophthalmol; 2002 Sep; 120(9):1162-73. PubMed ID: 12215089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.